Skip to content
Home / Media Hub / Resource Library / Minimizing Risk In API & Drug Product Development & Manufacturing: A Fully Integrated Supply Chain

Minimizing Risk In API & Drug Product Development & Manufacturing: A Fully Integrated Supply Chain

White Papers

C&EN White Paper brought to you by CordenPharma

The pharmaceutical and biopharma industry continues to experience solid growth in an expanding global market. This market growth has been accompanied by an ever-changing industry landscape, with consolidation among long-time “big pharma” leaders, ongoing mergers and acquisitions, and the emergence of start-ups and technology-based offshoots from academic laboratories. As the industry continuously adapts to evolving market pressures, the trend toward outsourcing of APIs & Drug Products to CDMOs with specialized capabilities, expertise and infrastructure remains a strong one.

Download the whitepaper here.

Want to find out more?

Get in touch with our team of experts to explore bespoke end-to-end CDMO support of your complete drug lifecycle
at any scale.